ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

Miller, D. T., Lee, K., Abul-Husn, N. S., Amendola, L. M., Brothers, K., Chung, W. K., Gollob, M. H., Gordon, A. S., Harrison, S. M., Hershberger, R. E., Klein, T. E., Richards, C. S., Stewart, D. R., & Martin, C. L. (2022). ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 24(7), 1407–1414. https://doi.org/10.1016/j.gim.2022.04.006
Authors:
David T. Miller
Kristy Lee
Noura S. Abul-Husn
Laura M. Amendla
Kyle Brothers
Wendy K. Chung
Michael H. Gollob
Adam S. Gordon
Steven M. Harrison
Ray E. Hershberger
Teri E. Klein
Carolyn Sue Richards
Douglas R. Stewart
Christa Lese Martin
ACMG Secondary Findings Working Gr
Affiliated Authors:
Wendy K. Chung
Columbia Affiliation:
Author Keywords:
exome sequencing
genome sequencing
incidental findings
secondary findings
elink
Publication Type:
Article
Unique ID:
10.1016/j.gim.2022.04.006
PMID:
35802134
DOI:
10.1016/j.gim.2022.04.006
Journal:
Genetics in Medicine
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: